D. Western Therapeutics Institute, Inc. (4576.T)
JPY 108.0
(0.0%)
JPY 108.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 428.36 Million JPY | -4.4% |
| 2022 | 448.1 Million JPY | 8.13% |
| 2021 | 414.42 Million JPY | 16.55% |
| 2020 | 355.58 Million JPY | -38.75% |
| 2019 | 580.52 Million JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 104.81 Million JPY | -8.35% |
| 2024 Q2 | 118.7 Million JPY | 13.25% |
| 2023 Q4 | 114.37 Million JPY | -9.43% |
| 2023 Q3 | 126.28 Million JPY | 29.24% |
| 2023 Q2 | 97.71 Million JPY | 8.57% |
| 2023 Q1 | 90 Million JPY | -35.22% |
| 2023 FY | 428.36 Million JPY | -4.4% |
| 2022 FY | 448.1 Million JPY | 8.13% |
| 2022 Q3 | 99.12 Million JPY | 0.0% |
| 2022 Q4 | 138.94 Million JPY | 40.17% |
| 2021 FY | 414.42 Million JPY | 16.55% |
| 2020 FY | 355.58 Million JPY | -38.75% |
| 2019 FY | 580.52 Million JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 91.02% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -279.332% |
| GNI Group Ltd. | 26.01 Billion JPY | 98.353% |
| Linical Co., Ltd. | 12.3 Billion JPY | 96.52% |
| Trans Genic Inc. | 13.08 Billion JPY | 96.726% |
| MEDINET Co., Ltd. | 661.54 Million JPY | 35.248% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 91.696% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | 72.548% |
| AnGes, Inc. | 152.98 Million JPY | -180.004% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | 29.79% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 96.644% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | 47.549% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -216.117% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | 73.654% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | 77.469% |
| Chiome Bioscience Inc. | 682.46 Million JPY | 37.233% |
| Kidswell Bio Corporation | 2.43 Billion JPY | 82.381% |
| PeptiDream Inc. | 28.71 Billion JPY | 98.508% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -579.533% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -254.02% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -594850.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -973.944% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 90.503% |
| FunPep Company Limited | 530 Thousand JPY | -80723.396% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -518.576% |
| Stella Pharma Corporation | 269.49 Million JPY | -58.953% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -35.208% |
| Cuorips Inc. | 23.1 Million JPY | -1754.229% |
| K Pharma,Inc. | 1 Billion JPY | 57.164% |
| Takara Bio Inc. | 43.5 Billion JPY | 99.015% |
| ReproCELL Incorporated | 2.42 Billion JPY | 82.349% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | 75.027% |
| StemCell Institute Inc. | 2.48 Billion JPY | 82.736% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 82.962% |
| CellSeed Inc. | 190.13 Million JPY | -125.296% |